Dr. Hong-Yuan Chu received his PhD degree in neuropharmacology from the Shanghai Institute of Materia Medica (China) in 2010. He relocated to the United States to conduct postdoctoral research with positions at the National Institute of Mental Health (Bethesda, Maryland) and the department of physiology and Udall Center of Excellence in Parkinson’s Disease Research at Northwestern University (Chicago, Illinois). In 2019, Dr. Chu was recruited to the department of neurodegenerative science at the Van Andel Institute (Grand Rapids, Michigan), and in early 2024, he joined the department of pharmacology and physiology at Georgetown University, where he is currently an associate professor. His laboratory uses multiple technologies to understand how progressive degeneration of dopamine neurons alters the connectivity and function of cortico-basal ganglia-thalamocortical circuits, and how such changes contribute to the motor deficits in Parkinson’s disease. Dr. Chu holds research awards from the National Institutes of Health.